Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Multi-target organ effect: The application of PDE5i in the treatment of erectile dysfunction and male health management].

Created on 11 Nov 2026

Authors

Zheng Li, Hongjun Li, Xuejun Shang

Published in

Zhonghua nan ke xue = National journal of andrology. Volume 32. Issue 5. Pages 385-388.

Abstract

Erectile dysfunction (ED) is one of the most prevalent male sexual dysfunctions, with its global prevalence continuing to rise alongside the aging population. Since the introduction of phosphodiesterase 5 inhibitor (PDE5i) in 1998, these agents have not only served as the first-line oral therapy for ED, improving the quality of life for hundreds of millions of patients, but have also profoundly driven the overall advancement of the field of men's health. This paper systematically reviews the research and development history and the evolution of clinical practice regarding PDE5i. It elucidates their "multi-target organ effects", which have expanded from the regulation of a single target organ-the corpus cavernosum-to multiple therapeutic areas, including pulmonary arterial hypertension, benign prostatic hyperplasia, cardiovascular protection, male reproduction, and neurodegenerative diseases. Furthermore, the article provides an in-depth discussion on how PDE5i has reshaped the diagnostic and therapeutic paradigm of ED, including the simplification of diagnostic concepts, enhanced patient engagement, and the strategic transition from on-demand dosing to regular treatment. At the same time, the importance of rational drug use under the background of expanded application scope will be discussed as well. The developmental trajectory of PDE5i is not merely a history of innovation for a single class of drugs, but a classic paradigm of "drug repurposing and multi-target expansion" in the pharmaceutical industry, providing a critical reference for full-life male health management in the era of precision medicine.

PMID:
43012226
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 31
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement